摘要
30多年来,III型设备已用于有监督和无监督环境下睡眠呼吸障碍的诊断。在检测阻塞性睡眠呼吸暂停和中枢性睡眠呼吸暂停的人群中,它们具有令人满意的阳性和阴性预测值,这些事件的症状在测试前有中等高的概率。然而,商业上可用的III型设备的标准化从未进行过,技术规格可能差别很大。它们都没有像医学领域的大多数其他诊断方式一样经过严格的程序。虽然III型设备不包括夜间脑电图信号的采集,但使用美国睡眠医学学会概述的标准进行呼吸事件评分所需的物理传感器的最低数量仍然存在争议。本技术标准从成人和儿童睡眠实践的多个角度总结了2007年以来发表的III类研究的数据。最重要的是,它旨在提供一个框架,以考虑当前III类设备在诊断睡眠呼吸障碍方面的局限性,同时提出与研究和实践相关的问题,旨在改善我们在现在和未来对这些设备的使用。
摘要
本技术标准提供了一个考虑当前III类设备限制的框架,同时提出了旨在改善我们在现在和未来使用这些设备的研究和实践相关问题https://bit.ly/3KikOhS
脚注
本文件于2022年8月17日由ERS执行委员会批准。
利益冲突:T. Penzel报告了brainbra、Jazz Pharma、Löwenstein Medical、国家睡眠基金会和Neuwirth的个人演讲费用;拜耳医疗保健和brain的咨询费;Jazz Pharma和Nukute的差旅支持;参与Nukute和Cerebra的顾问委员会;持有The siestgroup、Nukute和Advanced Sleep Research的股票或股票期权;从Neurovirtual接收设备;拜耳医疗保健、Cidelec、Löwenstein Medical、诺华和施普林格Publisher提供的机构费用和研究资助。T. Penzel还报告了以下领导角色:德国睡眠学会(主席,无薪),IEEE医学和生物学工程(咨询委员会成员,无薪),德国生物医学工程学会(董事会成员,无薪),DIN -德国标准化机构(委员会成员,无薪)。W. Randerath负责飞利浦呼吸器、Heinen & Löwenstein、Jazz Pharmaceuticals、Weinmann、Resmed、Inspire、Vanda Pharma和Bioprojet的机构费用、研究经费和演讲费用的报告,他是欧洲呼吸学会大会4(睡眠障碍呼吸)的负责人。188bet官网地址R.L. Riha报告了一次性个人演讲费用,并参加了Jazz制药公司的咨询委员会,同时也是睡眠咨询有限公司的联合董事。 D. Testelmans reports institutional fees and educational grants from AirLiquide, Philips Respironics and Resmed. J. Verbraecken reports institutional fees and educational grants from Accuramed, Agfa-Gevaert, AirLiquide, AstraZeneca, Bekaert Deslee Academy, Bioprojet, Desitin, Ectosense, Fisher & Paykel, Heinen & Löwenstein, Idorsia, Inspire, Jazz Pharmaceutics, Medidis, Mediq Tefa, MSD, NightBalance, OSA Academy, OSG, Oxford Pharmagenesis, Philips Respironics, ResMed, Sanofi, SomnoMed, Springer, Total Care, UCB Pharma, Vivisol, Wave Medical and Westfalen Medical; consulting fees from Vermedia; and reports the following leadership roles: president (up to August 2021) and past president of the Belgian Association for Sleep research and Sleep medicine (since September 2021). M. Celmina reports lecture honoraria from Rare Diseases Conference and Latvian Medical Association; support to attend various conferences (IPSA, Baltic Sleep Meeting, Nordic Sleep Meeting) provided by Children's Clinical University Hospital (Riga, Latvia); and is a member of the board of the Latvian Sleep Medicine Society. A. Morley reports lecture honoraria from Sleep Consultancy Ltd and Sleep Scotland; participation on advisory board for the BTS Guideline for Pediatric Sleep Disorders; and is a board member of Association of Respiratory Technology and Physiology – Sleep. L. Roberti reports grants/funding to AAI ETS patient organisations from Resmed, Fisher & Paykel, Jazz Ph, Bioprojet, Vitalaire, Linde, Medicair, Philips, Olympus, Respiraire and Vivisol; and also reports the following leadership roles: President of Associazione Apnoici Italiani ETS (Italian Sleep Apnoea Patient Association), Sleep Apnoea Patient Representative of EMA, and Member of ELF Sleep Apnoea PAG. W. Ruehland reports travel support from Institute for Breathing and Sleep to attend Sleep Downunder and TSANZSRS Conferences, and from Australian and New Zealand Sleep Science Association to attend Sleep Downunder conference; and also reports the following leadership roles: board member of the Australian and New Zealand Sleep Science Association, committee member of the Medical and Scientific Research Committee, Institute for Breathing and Sleep, and is director of Respiratory Quality Assurance Pty Ltd, which provides PSG scoring external proficiency testing program (QSleep) for sleep centres. G. Grundström is Chairman of the Swedish Sleep Apnea Association. B. Cooper, R. Hamutcu-Ersu, A. Kaditis, A. Pataka and A. van Eyck have no conflict of interest to disclose related to the topic discussed in this technical standard.
支持声明:该项目的参与者获得了来自欧洲呼吸学会(TF-2019-16)的资助,用于协助文献搜索和编辑手稿。188bet官网地址本文的资助信息已存入交叉参考基金注册.
- 收到了2022年2月25日。
- 接受2022年7月27日。
- 版权所有©作者2023。有关复制权利和权限,请联系权限在}{ersnet.org